IVIg vs different infusion regimens of IVIG
Incidence of any adverse effects after treatment initiation ( · people undergoing initial treatment for KD
Primary treatment with intravenous immunoglobulin (IVIG) showed no clear difference in incidence of any adverse effects after treatment initiation ( compared with different infusion regimens of IVIG (low certainty).
1 finding from 1 review
- Intravenous immunoglobulin for the treatment of Kawasaki disease 2023 · Cochrane Headline outcomes onlyOR 1.11 [0.52, 2.37]6 studies · 1659 participantsLow